Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Neuvogen Announces Next Generation Cancer Vaccine Strategy to Transform How Solid Tumors are Treated
Details : NEUVOGEN’s whole cell vaccine immunotherapy platform is designed to simultaneously prime the broadest array of targets, impacting multiple biologic pathways with the goal of directing an immune response against overlapping targets on every cell within ...
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
January 20, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable